Our products are for in vitro research use only, not for clinical diagnosis

Recently added:

    in total 0 items Total 0

    Language:

    All
    • All
    • Products
    • News
    • Introduction
    • FAQ
    • Video
    • Gallery
    All
    • All
    • Products
    • News
    • Introduction
    • FAQ
    • Video
    • Gallery
    undefined
    undefined
    undefined
    undefined
    +
    • undefined
    • undefined
    • undefined
    • undefined

    SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit

    Item No:

    E-EL-E600

    Chinese Name:

    Alias:

    COVID 19 IgG,N protein IgG

    Classification:

    Retail Price

    ¥ 2400

    Market Price

    ¥ 1


    The kit uses an indirect ELISA method. The recombinant purified SARS-CoV-2 Nucleocapsid protein (N protein) is pre-coated on the enzyme plate. The anti-SARS-CoV-2 Nucleocapsid protein IgG antibody in the sample or positive control will bind to the precoated SARS-CoV-2 Nucleocapsid protein antigen on the ELISA plate, and the free components will be washed away. Horseradish peroxidase-labeled mouse anti-human IgG secondary antibody is then added to form a SARS-CoV-2 nuclear coat protein antigen-anti-SARS-CoV-2 nuclear coat protein IgG-mouse anti-human IgG secondary antibody immune complex, and the free components are washed away. The chromogenic substrate (TMB) was added, and TMB appeared blue catalyzed by horseradish peroxidase and turned yellow after the addition of termination solution.
    • Spec
      • 48T
      • 96T
      • 96T*5
    Quantity
    -
    +

    Inventory surplus

    3

    隐藏域元素占位

    Close
    • Product Comparison
    Total X Clear all

    Describe

    Product Properties


    Product specification 96T,96T*5
    Experiment Length 1.5h
    Sample type Human serum, plasma
    Sample volume 100 μL
    Storage conditions 2-8℃
    Test range Qualitative Assay
    Product use This kit is used for the in vitro qualitative detection of SARS-CoV-2 IgG in human serum and plasma.
    Repeatability Both intra-batch CV & inter-batch CV are less than 10%.
    Product alias COVID 19 IgG,N protein IgG
    Experiment type Indirect-ELISA

     

    Detection principle


        The kit uses an indirect ELISA method. The recombinant purified SARS-CoV-2 Nucleocapsid protein (N protein) is pre-coated on the enzyme plate. The anti-SARS-CoV-2 Nucleocapsid protein IgG antibody in the sample or positive control will bind to the precoated SARS-CoV-2 Nucleocapsid protein antigen on the ELISA plate, and the free components will be washed away. Horseradish peroxidase-labeled mouse anti-human IgG secondary antibody is then added to form a SARS-CoV-2 nuclear coat protein antigen-anti-SARS-CoV-2 nuclear coat protein IgG-mouse anti-human IgG secondary antibody immune complex, and the free components are washed away. The chromogenic substrate (TMB) was added, and TMB appeared blue catalyzed by horseradish peroxidase and turned yellow after the addition of termination solution. The OD value was measured at 450 nm using an enzyme marker and compared with the calculated Cut Off value to qualitatively determine whether anti-SARS-CoV-2 nucleocapsid protein IgG antibody was present in the test sample.

     

    Operation steps


    162 1. Add 100 μL of the sample and the quality control to the corresponding plate wells and incubate at 37°C for 45 minutes.
     
    162 2. Discard the liquid in the plate and wash the plate 3 times.
    162 3. Add 100uL of binding solution to each well and incubate at 37°C for 30 minutes. Discard the liquid in the plate and wash the plate 5 times.
     
    162 4. Add 90 μL of the conjugate solution to each well and incubate at 37C for about 15 minutes.
    162 5. . Add 50μL of stop solution to each well
     
    158 6. Read immediately at 450nm and process the data

     

    Welcome your message

    Our staff will contact you within 24 hours (working days), if you need other services, welcome to consult:400-027-8858
    左旋星
    图片名称

    Contact Us

    Phone: 400-027-8858

    Fax: 027-86627593

    Address:A101, Building C1, Bio City, No.666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan

    Copyright © 2023Wuhan Reivaa Biotech Co., Ltd.

     SEO  |  Business license  |  IPv6 access support

    SEO  Business license  

    IPv6 access support

    WhatsApp:400-027-8858

    Add:A101, Building C1, Bio City, No.666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan

    E-mail: mail@reivaa.com

    We will give you feedback in time